Clinical Trials Directory

Trials / Unknown

UnknownNCT04774133

The Immunodynamic Effect of Radiotherapy in Prostate Cancer Patients.

Radioinduced Modifications of Lymphocyte Subpopulations Involved in Resistence and Escape Mechanisms to Radiation Therapy of Localized Prostate Cancer.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Regina Elena Cancer Institute · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

Radiotherapy has an important role in the treatment of prostate cancer both as curative treatment and postoperative or salvage ones. Several studies demonstrated a significant reduction of lymphocytes during RT but there are only a few studies monitoring these cells in the treatment of prostate cancer. This study will enroll 50 patients with hystologically proven prostate cancer who will undergo to radiotherapy according to Institutional protocols. This study aims to evaluate the effect of RT on immuno-regulatory B, NK, T, B and T lymphocyte subpopulations (Breg and Treg) and plasma cells, quantitative / qualitative changes,their correlations with the clinical course of the disease and acute and late toxicity. In parallel, using multicolor panels (12 colors) we will evaluate the expression of inhibitory checkpoints and TGFβ signaling. The final objective is to identify new therapeutic targets to be combined with RT.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBlood samplePazients will undergo to blood samples at predefined times

Timeline

Start date
2019-02-14
Primary completion
2021-02-25
Completion
2022-01-01
First posted
2021-03-01
Last updated
2021-03-01

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04774133. Inclusion in this directory is not an endorsement.